Critical Care

official impact factor 4.60

Open Access Highly Access

Importance of nondrug costs of intravenous antibiotic therapy

Arthur RH van Zanten*, Peter M Engelfriet, Karin van Dillen, Miriam van Veen, Mark JC Nuijten and Kees H Polderman

Critical Care 2003, 7:R184-R190 doi:10.1186/cc2388


See related Commentary: http://ccforum.com/content/7/6/420

Accesses  

  • Last 30 days: 69 accesses
  • Last 365 days: 924 accesses
  • All time: 15581 accesses